1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Metabolomics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Metabolomics Instruments
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Metabolomics Bioinformatics Tools and Services
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Indication
7.1 Cancer
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cardiovascular Disorders
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Neurological Disorders
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Inborn Errors of Metabolism
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Application
8.1 Biomarker and Drug Discovery
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Toxicology
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Nutrigenomics
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Personalized Medicine
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Agilent Technologies Inc.
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 Biocrates Life Sciences AG
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.3 Bio-Rad Laboratories Inc.
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.3.4 SWOT Analysis
13.3.4 Bruker Corporation
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.5 Danaher Corporation
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.5.4 SWOT Analysis
13.3.6 Human Metabolome Technologies Inc.
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Financials
13.3.7 Metabolon Inc.
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.8 Shimadzu Corporation
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.8.4 SWOT Analysis
13.3.9 Thermo Fisher Scientific Inc.
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10 Waters Corporation
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 Financials
13.3.10.4 SWOT Analysis
List of Figures
Figure 1: Global: Metabolomics Market: Major Drivers and Challenges
Figure 2: Global: Metabolomics Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Metabolomics Market: Breakup by Product (in %), 2024
Figure 4: Global: Metabolomics Market: Breakup by Indication (in %), 2024
Figure 5: Global: Metabolomics Market: Breakup by Application (in %), 2024
Figure 6: Global: Metabolomics Market: Breakup by Region (in %), 2024
Figure 7: Global: Metabolomics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 8: Global: Metabolomics (Metabolomics Instruments) Market: Sales Value (in Million USD), 2019 & 2024
Figure 9: Global: Metabolomics (Metabolomics Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 10: Global: Metabolomics (Metabolomics Bioinformatics Tools and Services) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Metabolomics (Metabolomics Bioinformatics Tools and Services) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Metabolomics (Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Metabolomics (Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Metabolomics (Cardiovascular Disorders) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Metabolomics (Cardiovascular Disorders) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Metabolomics (Neurological Disorders) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Metabolomics (Neurological Disorders) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Metabolomics (Inborn Errors of Metabolism) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Metabolomics (Inborn Errors of Metabolism) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Metabolomics (Other Indications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Metabolomics (Other Indications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Metabolomics (Biomarker and Drug Discovery) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Metabolomics (Biomarker and Drug Discovery) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Metabolomics (Toxicology) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Metabolomics (Toxicology) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Metabolomics (Nutrigenomics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Metabolomics (Nutrigenomics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Global: Metabolomics (Personalized Medicine) Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Global: Metabolomics (Personalized Medicine) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Global: Metabolomics (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Global: Metabolomics (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: North America: Metabolomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: North America: Metabolomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: United States: Metabolomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: United States: Metabolomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Canada: Metabolomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Canada: Metabolomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: Asia Pacific: Metabolomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: Asia Pacific: Metabolomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: China: Metabolomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: China: Metabolomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: Japan: Metabolomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: Japan: Metabolomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: India: Metabolomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: India: Metabolomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: South Korea: Metabolomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: South Korea: Metabolomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: Australia: Metabolomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: Australia: Metabolomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Indonesia: Metabolomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Indonesia: Metabolomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: Others: Metabolomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: Others: Metabolomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: Europe: Metabolomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: Europe: Metabolomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: Germany: Metabolomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: Germany: Metabolomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: France: Metabolomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: France: Metabolomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: United Kingdom: Metabolomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: United Kingdom: Metabolomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Italy: Metabolomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Italy: Metabolomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Spain: Metabolomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Spain: Metabolomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: Russia: Metabolomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: Russia: Metabolomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: Others: Metabolomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: Others: Metabolomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Latin America: Metabolomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Latin America: Metabolomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Brazil: Metabolomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Brazil: Metabolomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Mexico: Metabolomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: Mexico: Metabolomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 76: Others: Metabolomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 77: Others: Metabolomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 78: Middle East and Africa: Metabolomics Market: Sales Value (in Million USD), 2019 & 2024
Figure 79: Middle East and Africa: Metabolomics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 80: Global: Metabolomics Industry: SWOT Analysis
Figure 81: Global: Metabolomics Industry: Value Chain Analysis
Figure 82: Global: Metabolomics Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Global: Metabolomics Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Metabolomics Market Forecast: Breakup by Product (in Million USD), 2025-2033
Table 3: Global: Metabolomics Market Forecast: Breakup by Indication (in Million USD), 2025-2033
Table 4: Global: Metabolomics Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 5: Global: Metabolomics Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 6: Global: Metabolomics Market: Competitive Structure
Table 7: Global: Metabolomics Market: Key Players